Literature DB >> 21093354

Spectroscopic studies on the interaction of cilostazole with iodine and 2,3-dichloro-5,6-dicyanobenzoquinone.

M Pandeeswaran1, E H El-Mossalamy, K P Elango.   

Abstract

The electron accepting properties of the 2,3-dichloro-5,6-dicyanobenzoquinone and iodine and electron donating properties of the drug cilostazole have been studied using the UV-vis, FT-IR, GC-MS and Far-IR techniques. The interaction of cilostazole drug with iodine and 2,3-dichloro-5,6-dicyanobenzoquinone resulted via the initial formation of charge-transfer complex as an intermediate. The rate of formation of the product have been measured and discussed as a function of solvent and temperature. The complexes have been found by Job's method of continuous variation revealed that the stoichiometry of the complexes in both the cases was 1:1. The enthalpies and entropies of formation of the complexes have been obtained by determining their rate constant at three different temperature. The ionization potential of the donor was determined using the charge-transfer absorption bands of the complexes and the same was found comparable with that computed using MOPAC PM3 method. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093354     DOI: 10.1016/j.saa.2010.10.023

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  2 in total

1.  One-pot synthesis of novel 1-(1H-tetrazol-5-yl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine derivatives via an Ugi-azide 4CR process.

Authors:  Mehdi Ghandi; Saleh Salahi; Abuzar Taheri; Alireza Abbasi
Journal:  Mol Divers       Date:  2017-12-11       Impact factor: 2.943

2.  A Systematic Approach to the Development of Cilostazol Nanosuspension by Liquid Antisolvent Precipitation (LASP) and Its Combination with Ultrasound.

Authors:  Emilia Jakubowska; Bartłomiej Milanowski; Janina Lulek
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.